Ceva launches novel vaccine to protect pigs from common respiratory disease

Ceva Santé Animale announced on Thursday that it has launched a new vaccine in Europe to prevent Mycoplasma hyopneumoniae, a bacterial respiratory disease that affects 90% of the world's swine farms. When administered at weaning, the vaccine protects pigs for up to 26 weeks, offering a longer period of protection than most competing products, the company said in a press release. A single shot is designed to keep the animals healthy throughout the fattening period, which will also help farmers cut down on the controversial prophylactic use of antibiotics, the company says. Ceva has also introduced a mobile app to help farmers track bacterial pathogens and target vaccinations according to the needs of individual herds. Release

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…